A subgroup analysis of the MiroCIP study to evaluate chemotherapy-induced peripheral neuropathy: symptom profile, severity, and analgesia efficacy depending on type of chemotherapy

Authors

Kazuhito Shiosakai
Satoshi Kuwabara (ORCID: https://orcid.org/0000-0002-4716-8578)
Mamoru Takada
Tadamichi Denda (ORCID: https://orcid.org/0000-0003-2570-9692)
Aoi Hino
Tomoki Suichi (ORCID: https://orcid.org/0000-0002-9575-9444)
Yoichi Naito (ORCID: https://orcid.org/0000-0002-8490-9064)
Takahiro Kogawa (ORCID: https://orcid.org/0000-0003-3730-6591)
Ai Miyoshi (ORCID: https://orcid.org/0000-0003-0229-2513)
Takuji Suzuki (ORCID: https://orcid.org/0000-0003-0416-6641)
Sho Kodama
Sonoko Misawa (ORCID: https://orcid.org/0000-0002-8533-5664)

Institutions

Chiba University (JP)
Shanghai Institute for Science of Science (CN)
Daiichi Sankyo (United Kingdom) (GB)
Chiba Cancer Center (JP)
Teikyo University Chiba Medical Center (JP)
The Cancer Institute Hospital (JP)
National Cancer Center Hospital East (JP)
Institute of Science Tokyo (JP)

Publication Details

Journal: Expert Opinion on Pharmacotherapy
Published: 2025-04-27
DOI: https://doi.org/10.1080/14656566.2025.2499665
Citations: 2
Primary Topic: Cancer Treatment and Pharmacology
Type: article
Field-Weighted Citation Impact: 2.09

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

A subgroup analysis of the MiroCIP study to evaluate chemotherapy-induced peripheral neuropathy: symptom profile, severity, and analgesia efficacy depending on type of chemotherapy

Kazuhito Shiosakai, Satoshi Kuwabara, Mamoru Takada, Tadamichi Denda et al.

Apr 27, 2025

2 citations

Expert Opinion on Pharmacotherapy

Cancer Treatment and Pharmacology

2.09

article

A subgroup analysis of the MiroCIP study to evaluate chemotherapy-induced peripheral neuropathy: symptom profile, severity, and analgesia efficacy depending on type of chemotherapy

Kazuhito Shiosakai, Satoshi Kuwabara, Mamoru Takada, Tadamichi Denda, Aoi Hino, Tomoki Suichi, Yoichi Naito, Takahiro Kogawa, Ai Miyoshi, Takuji Suzuki, Sho Kodama, Sonoko Misawa

April 27, 2025article en

2 citations

Abstract

No abstract available for this paper.

Expert Opinion on PharmacotherapyVol. 26(8)

Chiba University (JP), Shanghai Institute for Science of Science (CN), Daiichi Sankyo (United Kingdom) (GB), Chiba Cancer Center (JP), Teikyo University Chiba Medical Center (JP), The Cancer Institute Hospital (JP), National Cancer Center Hospital East (JP), Institute of Science Tokyo (JP)

Zero hunger

Openalex Percentile: Top 13%

Cancer Treatment and Pharmacology

2.09

DOI Source OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

A subgroup analysis of the MiroCIP study to evaluate chemotherapy-induced peripheral neuropathy: symptom profile, severity, and analgesia efficacy depending on type of chemotherapy — Kazuhito Shiosakai, Satoshi Kuwabara, et al. · Expert Opinion on Pharmacotherapy (2025) | TGRS Research Map | TGRS